Partnership with Northway Biotech (CDMO)
Micreos Pharmaceuticals partners with Biologics CDMO Northway Biotech for its engineered[…]
Introducing MEndoB: A Precision Biologic Targeting Staphylococcus aureus
MICREOS is pleased to introduce MEndoB, our lead engineered endolysin and[…]
New Data Published in Blood Supports the Potential of Engineered Endolysins in CTCL
A study from the University of Copenhagen, published in Blood, provides[…]